This information was published on 2025-05-29T02:38:25 for IP Right Filed Published.
| Field | Value |
| (210) | 2551894 (IR 1856842) |
| (220) |
18 Apr 2025
|
| (300) |
US, 27 Nov 2024, 98876362
|
| (511) (510) |
Class 5
Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders. |
| (540) | ZENROSIB |
| (550) | Word |
| (730) |
Nuvalent, Inc.
|
Find out more about publications on the About page.